Technologies

The technology, developed by CNR-ICB, is based on an innovative bioprocess called "Caphnophilic (CO2-requiring) Lactic Fermentation (CLF)”, developed in the hyperthermophilic bacterium Thermotoga neapolitana (EP patent: EP2948556B1), which allows the production of "green" hydrogen and capture and valorization of CO2 in L -lactic acid (98% e.e.).

The current technology allows to achieve new macroporous superadsorbent polymeric materials able to remove toxic contaminants from water and soil showing excellent sequestering properties against arsenate As (V), chromate Cr (VI) and Borate B (III) ions. The material is obtained by radical cryopolymerization of the monomer 4'-vinyl-benzyl-N-methyl-D-glucamine and / or its mixtures with hydroxyethyl-methacrylate (HEMA).

Uniform coverage with porous layers over extended surfaces is beneficial for many purposes. Depending on the nature/composition, thickness and interfaces of the layer, this kind of special coverage can assure pivotal properties such as transparency, bendability, high surface reactivity, intermixing capability. In the long list of desired porous materials, transparent oxides find application in the fields of Photovoltaics, Sensing, Photocatalysis, Water Purification and Splitting, Lithium Batteries and many more.

Our team can develop low-cost ultra-flexible sensors integrated on plastic substrate for volatile organic compounds (VOCs) and gas detection. These devices combine scalable fabrication technologies, implementing active materials such as nanostructured metal oxides or stack of nanostructures decorated with metal nanoparticles, thus enabling a high sensitivity (in the range of hundreds of ppb). These devices can be applied to numerous industrial and commercial sectors and they can be embedded in systems that are more sophisticated.

Safe, efficient and specific nano-delivery systems are increasingly needed for precision and regenerative medicine and targeted therapies (e.g. anticancer and antimicrobial therapies), as well as for  the cosmetic and nutraceutical sectors’ applications. Despite the appreciable success of synthetic nanovectors, like for example liposomes, their clinical and market application is hampered by some limitations: • large scale production, • low cost production • intrinsic toxicity • limited cellular uptake • limited consumer acceptance.